Randomized double-blind placebo-controlled trial of powdered Brassica rapa ethanol extract on alteration of body composition and plasma lipid and adipocytokine profiles in overweight subjects.

@article{Jeon2013RandomizedDP,
  title={Randomized double-blind placebo-controlled trial of powdered Brassica rapa ethanol extract on alteration of body composition and plasma lipid and adipocytokine profiles in overweight subjects.},
  author={Seon Suk Jeon and Ji-Eun Kim and Su-kyung Shin and Eun-young Kwon and Un Ju Jung and Nam-In Baek and Kumbae Lee and Tae Sook Jeong and Hae Gon Chung and M-K. Choi},
  journal={Journal of medicinal food},
  year={2013},
  volume={16 2},
  pages={
          133-8
        }
}
We evaluated the effects of Brassica rapa ethanol extract (BREE) on body composition and plasma lipid profiles through a randomized, double-blind, and placebo-controlled trial in overweight subjects. Fifty-eight overweight participants (age 20-50 years, body mass index23.0-24.9) were randomly assigned to two groups and served BREE (2 g/day) or placebo (starch, 2 g/day) for 10 weeks. Body compositions, nutrients intake, plasma lipids, adipocytokines, and hepatotoxicity biomarkers were assessed… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Arvelexin isolated from the Brassica rapa abolishes inducible NF-kB activation by inhibiting IKK activation, thereby suppressing NF-kB-regulated pro-inflammatory gene expression

  • JS Shin, YS Noh, Y Lee
  • Br J Pharmacol
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…